UK science minister Lord Paul Drayson's Sensyne Health has raised £60m ($77m) through the placing of 34.3 million shares. The company is developing a drug to treat Alzheimer's disease and other forms of dementia.
UK science minister Lord Paul Drayson's Sensyne Health has raised £60m ($77m) through the placing of 34.3 million shares. Sensyne develops healthcare technologies that rely on AI to create products and services.